Answer
Ropeginterferon alfa-2b has a terminal half-life of approximately 6–10 days in patients after repeated subcutaneous administration at doses of 50–500 micrograms.
Sources for this answer
- Besremi 250 micrograms/0.5 mL solution for injection in pre-filled penAOP Orphan Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 10Document updated
Sources checked